-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

637. Myelodysplastic Syndromes – Clinical and Epidemiological: Poster II

Symposia: Myelodysplastic Syndromes – Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 11, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Luis E. E. Aguirre, MD1, Najla Al Ali, MS2, Somedeb Ball, MD1*, Avani M Singh, MD1, Akriti G Jain, MD3, Onyee Chan, MD1*, Zaker I. Schwabkey, MD1, Sara M Tinsley-Vance, PhD, ANP1, Andrew Kuykendall, MD1, Kendra Sweet, MD1, Jeffrey E. Lancet, MD1, Eric Padron, MD1, David A. Sallman, MD2 and Rami S. Komrokji, MD1

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, WESLEY CHAPEL, FL

Mark Gurney, MB BCh BAO1*, Ismahene Chekkaf, MD1*, Rong He, MD2, David S. Viswanatha, MD3, Patricia Greipp, DO2, Abhishek A. Mangaonkar, MBBS1, Kebede Begna, MD4, Naseema Gangat, MBBS1, Mrinal M. M. Patnaik, MD1, Mark R. Litzow, MD1, James M. Foran, MD5, Talha Badar, MD6, Mithun V. Shah, MD, PhD1, Hassan B. Alkhateeb, MD1* and Aref Al-Kali, MD1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
3Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
4Divison of Hematology, Mayo Clinic, Rochester, MN
5Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
6Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL

Christina K Ferrone, BSc1, Amy JM McNaughton, PhD1*, Iran Rashedi, MD PhD2*, Rena Buckstein3, Hubert Tsui, MD, PhD, FRCPC3 and Michael J Rauh, MD PhD1

1Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada
2Sunnybrook Health Sciences Centre, Toronto, ON, Canada
3Division of Hematological Pathology, Precision Diagnostics and Therapeutics Program, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Rami S. Komrokji, MD1, Luis E. E. Aguirre, MD1, Najla Al Ali, MS1, Onyee Chan, MD2*, Andrew Kuykendall, MD3, Kendra Sweet, MD1, Jeffrey E. Lancet, MD1, Eric Padron, MD1 and David A. Sallman, MD1

1Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, TAMPA, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Jose F. Falantes, MD1*, Francisco J. Márquez-Malaver, RN2*, Estrella Carrillo-Cruz, MD3*, Rosario M Morales-Camacho, PhD, MD2*, Concepción Prats-Martín, MD4*, Teresa Caballero, PhD5*, Eduardo Rodriguez Arbolí, MD4*, Ildefonso Espigado, MD, PhD6 and Jose A. Perez-Simon, MD, PhD4

1Hematology, Department of Hematology, Hospital Universitario Virgen del Rocío; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Seville, Spain
2Department of Hematology, Hospital Universitario Virgen del Rocío; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, Seville, Spain
3Hematology Department, Hospital Vírgen del Rocío, Instituto de Biomedicina (IBIS / CSIC / CIBERONC), Universidad de Sevilla, Seville, Spain
4Instituto de Biomedicina de Sevilla (IBiS), UGC-Hematología, Hospital Universitario Virgen del Rocío/ CSIC/ CIBERONC, Universidad de Sevilla, Sevilla, Spain
5Department of Hematology, Hospital Universitario Virgen del Rocio; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla,Spain, Sevilla, Spain
6Hematology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain

Dorela Lame1*, Marianeve Caprino2*, Elena Marinelli Busilacchi, PhD3*, Nadia Viola4*, Erika Morsia, MD5,6*, Michelangelo Pianelli, MD1*, Shahram Kordasti, MD, PhD7,8,9,10, Attilio Olivieri, MD6,11,12* and Antonella Poloni, PhD, MD13,14*

1Hematology, Università Politecnica Marche-Ospedali Riuniti Ancona Italy, Ancona, Italy
2Università Politecnica delle Marche, Ancona, Italy
3Hematology Clinic, Università Politecnica delle Marche, Ancona, Italy
4Ospedali Riuniti Ancona, Ancona, Italy
5Hematology, Clinic of Hematology, Rochester, MN
6Ospedali Riuniti di Ancona, Clinic of Hematology, Ancona, Italy
7Comprehensive Cancer Centre, School of Cancer and Pharmaceutical Sciences, King's College, London, United Kingdom
8Haematology Department, Guy's and St Thomas' NHS Trust, London, United Kingdom
9Department of Haematological Medicine, King's College Hospital NHS Foundation Trust, London, United Kingdom
10Department of Haematological Medicine, King's College London, London, United Kingdom
11Università Politecnica Delle Marche, Ancona, Italy
12Azienda Ospedali Riuniti di Ancona, Ancona University, Ancona, Italy
13Hematology, Università Politecnica delle Marche - AOU Ospedali Riuniti, Ancona, ITA
14Dipartimento di Medicina Interna, AOU Ospedali Riuniti, Ancona, Italy

Alessandro Bosi1*, Bruno Fattizzo, MD2,3*, Lorenzo Rizzo, MD4*, Silvia Ferrari, MD5*, Federico Lussana, MD, PhD6*, Lorenza Maria Borin7*, Andrea Castelli, MD8*, Paola Bianchi, PhD, BSc9, Wilma Barcellini, MD10*, Roberto Cairoli4*, Alfredo Molteni, MD11* and Marta Riva, MD12*

1Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy, Department of Oncology and Haemato-oncology, University of Milan, Milan, Italy, Segrate (milan), LA, Italy
2Haematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milano, Milano, Italy
3Department of Oncology and Oncohaematology, University of Milan, Milan, Italy
4Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
5Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
6Department of Oncology-Hematology, Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Please Choose A State, Italy
7Department of Hematology, San Gerardo Hospital, Monza, Italy
8Division of Hematology, Ospedale degli Infermi, Biella, Italy
9Hematology Unit, Pathophysiology of Anemias Unit, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
10Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
11Division of Hematology, ASST Cremona, Cremona, Italy
12Dipartimento di Ematologia, Oncologia e Medicina Molecolare, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy

John E. Pimanda, MBBS, FRACP, FRCPA, PhD1,2,3, Julie A.I. Thoms4*, Henry R. Hampton, PhD1*, Sarah Davidson5*, Swapna Joshi, MSc3*, Chowdhury H. Sarowar, PhD3*, Xin Ying Lim, PhD3*, Andrea C. Nunez, PhD3*, Purvi M. Kakadia, PhD6*, Russell Pickford, PhD7*, Mark Raftery, PhD8*, Sally Hough5*, Griselda Buckland5*, Michelle Bailey5*, Yuvaraj Ghodke5*, Noorul Absar5*, Lachlin Vaughan, MBBS, BSc, FRACP, FRCPA9*, Leonardo Pasalic, MBBS, PhD10*, Chun Yew Fong, MBBS, PhD, FRACP, FRCPA11, Melita Kenealy, MBBS, FRACP, FRCPA12*, Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA13, Rohanna Stoddart14*, Soma Mohammed9*, Linda Lee, PhD15*, Freda H. Passam, MD, PhD16, Kevin Spring, PhD17*, Kristy K. Skarratt18*, Patricia Rebeiro, MD19*, Stephen R Larsen, MBBS PhD FRACP FRCPA20, Peter Presgrave, MBBS, FRACP, FRCPA21*, William S Stevenson, MBBS, PhD, FRACP, FRCPA22, Silvia Ling, MBBS, PhD23, Campbell Tiley, MBBS FRACP FRCPA24, Stephen Fuller, MBBS, PhD18*, Fernando Roncolato25*, Anoop Kumar Enjeti, MBBS, FRCPA, MD, MRCP26, Dirk Hoenemann, MD27*, Charlotte Lemech, MD, FRACP28*, Stefan K. Bohlander, MD6, Jake Olivier, PhD29*, Mark Hertzberg, MD30, Ashwin Unnikrishnan, PhD3 and Mark N. Polizzotto, MBBS, FRACP, FRCPA31*

1School of Medical Sciences, University of New South Wales, Sydney, Australia
2Haematology Department, Prince of Wales Hospital, Sydney, Australia
3School of Clinical Medicine, University of New South Wales, Sydney, Australia
4School of Medical Sciences, University of New South Wales, Randwick, Australia
5Kirby Institute, University of New South Wales, Sydney, Australia
6Leukaemia & Blood Cancer Research Unit, Department of Molecular Medicine and Pathology, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand
7Bioanalytical Mass Spectrometry Facility, University of New South Wales, Sydney, Australia
8Bioanalytical Mass Spectrometry Facility, UNSW, Sydney, Australia
9Westmead Hospital, Sydney, Australia
10ICPMR, Department of Haematology, Westmead Hospital, Sydney, Australia
11Department of Haematology, Austin Health, Melbourne, Australia
12Cabrini Hospital, Melbourne, Australia
13Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia
14University of New South Wales, Sydney, Australia
15Royal North Shore Hospital, Sydney, Australia
16Haematology Research Group, Heart Research Institute, Sydney, NSW, Australia
17Liverpool Clinical School, Western Sydney University, Sydney, Australia
18Nepean Hospital, Sydney, Australia
19Blacktown Hospital, Sydney, Australia
20Institute of Haematology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
21Wollongong Hospital, Wollongong, Australia
22Department of Haematology, Royal North Shore Hospital, Sydney, NSW, Australia
23Liverpool Hospital, Sydney, Australia
24Central Coast Health, Gosford Hospital, Gosford, Australia
25St. George Hospital, Sydney, Australia
26Department of Haematology, Calvary Mater Hospital, Waratah, NSW, Australia
27Otway Pharmaceutical Development and Consulting Pty Ltd, Forrest, Australia
28Scientia Clinical Research, Medical Oncology, Prince of Wales Hospital, Sydney, Australia
29School of Mathematics and Statistics, University of New South Wales, Sydney, Australia
30Department of Clinical Haematology, Prince of Wales Hospital, Sydney, Australia
31ANU Clinical Hub for Interventional Research (CHOIR), John Curtin School of Medical Research, Canberra, Australia

Jing Dong, PhD1, Christopher Staffi Buradagunta2*, Tao Zhang, PhD3*, Stephen R. Spellman4*, Yung-Tsi Bolon, PhD4*, Paul Auer, phD5* and Wael Saber, MD, MS6

1Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
2MEDICAL COLLEGE OF WISCONSIN, Milwaukee, WI
3Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, MN
4CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN
5Division of Biostatistics, Institute for Health & Equity, and Cancer Center, MEDICAL COLLEGE OF WISCONSIN, Milwaukee, WI
6CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Wan Hsuan Lee1,2,3*, Chien-Chin Lin, MD, PhD4,5*, Cheng-Hong Tsai, MD, PhD5,6*, Mei-Hsuan Tseng, M.Sc.5*, Yuan-Yeh Kuo, Ph.D.5*, Ming-Chih Liu5*, Jih-Luh Tang, M.D., Ph.D.5,7, Hsun-I Sun8*, Yi-Kuang Chuang8*, Wen-Chien Chou, MD, PhD4,5, Hsin-An Hou, MD, PhD5* and Hwei-Fang Tien, MD, PhD5

1Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan
2Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan
3Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsin-Chu, Taiwan
4Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
5Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
6Department of Medical Education and Research, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan
7Department of Hematological Oncology, National Taiwan University Cancer Center, Taipei, Taiwan
8Tai-Cheng Stem Cell Therapy Center, National Taiwan University, Taipei, Taiwan

Lisa Johnson, PhD1*, Yajia Zhang1*, Biao Li1*, Lisa Aviles1*, Indu Lal1*, Giri Ramsingh2*, Naval Daver, MD3, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath4 and David A. Sallman, MD5

1Gilead Sciences Inc, Foster City, CA
2Gilead Sciences, Inc., Foster City, CA
3The University of Texas MD Anderson Cancer Center, Houston, TX
4Oxford University, Oxford, United Kingdom
5Moffitt Cancer Center, University of South Florida, Tampa, FL

Chen Wang, MD1*, Onyee Chan, MD2, Najla Al Ali, MS3, Andrew Kuykendall, MD2, Eric Padron, MD4, Kendra Sweet, MD2, Jeffrey E. Lancet, MD2, Rami S. Komrokji2 and David A. Sallman, MD3

1Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
3Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL

Roger M. Lyons, MD1, Wei-Han Cheng, PhD2*, Laura Moore-Schiltz3*, Ping Shi3*, Anders Svensson, MD2*, Cat N. Bui, PharmD2*, Jessica E. Hutti, PhD2*, Ann Marie McNeill, PhD2*, Elizabeth S. Mearns, PharmD4*, Archibong Yellow-Duke4* and Ira Zackon, MD1

1The US Oncology Network, The Woodlands, TX
2AbbVie, North Chicago, IL
3Ontada, The Woodlands, TX
4Genentech, A Member of the Roche Group, San Francisco, CA

Farah Fleti, MD1*, Amritpal Singh, MD1*, Aref Al-Kali, MD2, James M. Foran, MD3, Michelle A Elliott, MD2, Kebede Begna, MD4, Talha Badar, MD5, Nandita Khera, MD, MPH6, Mithun V. Shah, MD, PhD2, Hassan B. Alkhateeb, MD2*, Maymona Abdelmagid1*, Kaaren K. Reichard, MD7*, Rhett P. Ketterling, MD7*, Animesh Pardanani, MBBS, PhD 2, Naseema Gangat, MBBS2 and Ayalew Tefferi, MD2

1Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Division of Hematology/Oncology and Blood and Marrow Transplanation and Cellular Therapy, Mayo Clinic, Jacksonville, FL
4Divison of Hematology, Mayo Clinic, Rochester, MN
5Division of Hematology and Oncology, Mayo Clinic Florida, Jacksonville, FL
6Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ
7Division of Hematopathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

Tariq Kewan, MD1,2*, Waled Bahaj, MD3,4, Mai Aly, MD, BSc, MS5,6*, Arda Durmaz6,7*, Olisaemeka Ogbue8, Hetty E. Carraway, MD, MBA9, Abhay Singh, MD, MPH10, Suresh Kumar Balasubramanian, MD11,12, Mikkael A. Sekeres, MD13, Valeria Visconte, PhD14, Carmelo Gurnari, MD6,15 and Jaroslaw P. Maciejewski, MD, PhD, FACP6

1Smilow Cancer Center, Yale New Haven Hospital, New Haven, CT
2Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
3Brown Cancer Center, University of Louisville, Louisville, KY
4Cleveland Clinic Foundation, Cleveland, OH
5Assiut University, Clinical Hematology unit, Faculty of Medicine, Assiut, Egypt
6Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
7Case Western Reserve University, Systems Biology and Bioinformatics Department, School of Medicine, Cleveland, OH
8Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Rocky River, OH
9Department of Hematology and Medical Oncology, Taussig Cancer institute, Leukemia Program, Cleveland Clinic, Cleveland, OH
10Department of Hematology and Medical Oncology, Taussig Cancer Institute, Leukemia Program, Cleveland Clinic Foundation, Cleveland, OH
11Wayne State University, Detroit, MI
12Karmanos Cancer Institute/ Wayne State University, Detroit
13University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL
14Taussig Cancer Institute, Cleveland, OH
15Department of Biomedicine and Prevention, Ph.D. in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Rome, Italy

Luca Lanino1*, Prassede Salutari, MD2*, Alessandra Perego, MD3*, Bruno Fattizzo, MD4*, Marta Riva, MD5*, Marta Ubezio, MD1*, Pellegrino Musto, MD6, Daniela Cilloni, MD7*, Esther Natalie Oliva, MD8, Maria Teresa Voso, MD9, Anna Maria Pelizzari, MD10*, Antonella Poloni, PhD, MD11*, Isabella Capodanno, MD12*, Chiara Elena, MD13*, Claudio Fozza, MD14*, Fabrizio Pane, MD15, Massimo Breccia, MD16*, Marco De Gobbi, MD, PhD17*, Francesco Di Bassiano, MD18*, Daniela Barraco, MD19*, Elena Crisà, MD20*, Dario Ferrero, MD21*, Chiara Frairia, MD22*, Antonella Vaccarino, MD23*, Davide Griguolo, MD24*, Stefania Paolini, MD, PhD25*, Martina Quintini, MD26*, Mariarosaria Sessa, MD27*, Mauro Turrini, MD28*, Monica Bocchia, MD29*, Nicola Di Renzo, MD30*, Elisa Diral, MD31*, Cristina Foli, MD32*, Alfredo Molteni, MD33*, Ubaldo Occhini, MD34*, Giulia Rivoli, MD35*, Carmine Selleri, MD36, Roberto Bono, MD37*, Anna Calvisi, MD38*, Andrea Castelli, MD39*, Eros Di Bona, MD40*, Ambra Di Veroli, MD41*, Luana Fianchi, MD42*, Sara Galimberti, MD43*, Daniele Grimaldi, MD44*, Monia Marchetti45*, Marianna Norata, MD46*, Alessandro Rambaldi, MD47, Ilaria Tanasi, MD48*, Patrizia Tosi, MD49*, Ilaria Naldi, PhD50*, Valeria Santini, MD, PhD51* and Matteo G. Della Porta, MD1*

1Cancer Center, IRCCS Humanitas Research Hospital & Humanitas University, Rozzano - Milan, Italy
2Dipartimento Oncologia Ematologia, Ospedale Civile Spirito Santo, Pescara, Italy
3Ospedale San Gerardo, Monza, Italy
4Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico and University of Milan, Milan, Italy
5Dipartimento di Ematologia, Oncologia e Medicina Molecolare, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
6“Aldo Moro” University School of Medicine and AOU Consorziale Policlinico, Bari, Italy
7A.O. Ordine Mauriziano di Torino, Turin, Italy
8Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
9Policlinico Tor Vergata & Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
10UOC Ematologia, ASST Spedali Civili di Brescia, Brescia, Italy
11Dipartimento di Medicina Interna, AOU Ospedali Riuniti, Ancona, Italy
12Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, Reggio Emilia, RE, Italy
13Divisione di Ematologia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
14Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy
15Azienda Ospedaliera Universitaria Federico II, Naples, Italy
16Division of Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
17University of Turin and San Luigi University Hospital, Orbassano, Italy
18Ospedali Riuniti Villa Sofia - Cervello, Palermo, Italy
19Ospedale di Circolo, ASST Sette Laghi, Varese, Italy
20Division of Hematology, Department of Translational Medicine, Università del Piemonte Orientale Amedeo Avogadro, AOU Maggiore della Carità, Novara, Italy
21University of Turin/University Hospital A.O.U. “Città della Salute e della Scienza”, Turin, Italy
22AOU Città della Salute e della Scienza, Torino, Italy
23Ospedale San Giovanni Bosco, ASL Città di Torino, Torino, Italy
24Ospedale Maggiore, ASU GI, Trieste, Italy
25IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Bologna, Italy
26AO Perugia, Ospedale Santa Maria della Misericordia, Perugia, Italy
27Dipartimento di Scienze Mediche, Azienda Ospedaliero Universitaria di Ferrara, Ferrara, Italy
28Dep. of Internal Medicine, Valduce Hospital, Como, Italy
29Hematology, University of Siena, Azienda Ospedaliera Universitaria Senese, Siena, Italy, Siena, Italy
30UOC Ematologia e Trapianto di Cellule Staminali, PO Vito Fazzi, Lecce, Italy
31IRCCS Ospedale San Raffaele, Milan, Italy
32SSD Ematologia, ASL TO4, Chivasso - Ivrea, Italy
33Division of Hematology, ASST Cremona, Cremona, Italy
34Ospedale San Donato, USL Toscana Sud Est, Arezzo, Italy
35Ospedale Policlinico San Martino, UO Ematologia e Terapie Cellulari, Genova, Italy
36Hematology and Transplant Center, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Salerno, Italy
37Unità Trapianti di Midollo Osseo, Ospedali Riuniti Villa Sofia - Cervello, Palermo, Italy
38UOC Ematologia and CTMO, Ospedale "San Francesco", ASL Nuoro, Nuoro, Italy
39Division of Hematology, Ospedale degli Infermi, Biella, Italy
40UOC Oncoematologia, AULSS7 Pedemontana, Bassano del Grappa (VI), Vicenza, Italy
41Hematology, Belcolle Hospital, Viterbo, Italy
42Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
43UO Ematologia, AOU Santa Chiara, Pisa, Italy
44Ematologia, AO Santa Croce e Carle, Cuneo, Italy
45Division of Hematology, Hospital Antonio e Biagio and Cesare Arrigo, Alessandria, Italy
46IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
47Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII and University of Milan, Bergamo, Italy
48Section of Hematology, Department of Medicine, Verona University Hospital, Verona, Italy
49Hematology Unit, Infermi Hospital Rimini, Rimini, Italy
50Fondazione Italiana Sindromi Mielodisplastiche FISiM-ETS, Firenze, Italy
51Department of Experimental and Clinical Medicine, MDS Unit, Hematology, AOU Careggi - University of Florence, Firenze, Italy

Maria Julia Montoro Gómez, MD, PhD1*, Laura Palomo, PhD1*, Pablo Vidal2*, Francisco Fuster-Tormo3*, Esperanza Such, PhD4*, Margarita Ortega, PhD1*, Teresa González5*, Felix Lopez-Cadenas, MD6*, Sara Garcia-Avila, MD6*, Nieves Garcia-Gisbert6*, Elvira Mora Casterá, MD7*, Eugenia Rivero, MD8*, Francesc Bosch, MD, PhD1, Andrés Jerez, MD, PhD9*, Maria Diez-Campelo, MD10*, Francesc Solé, PhD11 and David Valcárcel, MD, PhD1

1Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
2Salamanca Universitu Hospital, Salamanca, Spain
3Cancer Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain
4Hematology Department., Hospital Universitario y Politécnico La Fe, Valencia, Spain
5Department of Hematology, University Hospital of Salamanca, Salamanca, Spain
6Group of Applied Clinical Research in Hematology, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain
7Department of Hematology, University Hospital La Fe, Valencia, Spain
8Department of Hematology, University Hospital Arnau de Vilanova, Lleida, Spain
9Hematology and Medical Oncology Department, Hospital Morales Meseguer, IMIB, Murcia, Spain, MURCIA, Spain
10Hematology Department, Hospital Universitario de Salamanca-IBSAL, Salamanca, Spain
11MDS Group. Institut de Recerca Contra la Leucèmia Josep Carreras (IJC), ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain

Samuel Urrutia, MD1, Koji Sasaki, MD2, Rashmi Kanagal-Shamanna, MD3, Alex Bataller, MD, PhD2*, Guillermo Montalban-Bravo, MD2, Irene Ganan-Gomez, PhD2, Yue Wei, PhD2, Hui Yang, MD, PhD2, Kelly S. Chien, MD2, Danielle Hammond, MD2, Carlos E. Bueso-Ramos, MD, PhD4, Sherry A. Pierce, BSN, BA2*, Hagop Kantarjian, MD5 and Guillermo Garcia-Manero, MD6

1MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Hematopathology, The University of Texas M D Anderson Cancer Center, Houston, TX
4Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Vishesh Khanna, MD1, Rong Lu, PhD2*, Jyoti Kumar, MD, MS3*, Henning Stehr, PhD4*, Michael A Spinner, MD5, Oscar Silva, MD, PhD4*, Sebastian Fernandez-Pol, MD, PhD4*, Jean S Oak, MD, PhD4*, Brent Tan, MD, PhD4* and Peter L Greenberg, MD5

1Division of Hematology, Department of Medicine, Stanford University Medical Center, Palo Alto, CA
2Department of Medicine, Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA
3Department of Pathology, Stanford University School of Medicine, Palo Alto, CA
4Department of Pathology, Stanford University School of Medicine, Stanford, CA
5Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, CA

Christina-Nefeli Kontandreopoulou1*, Stavroula Syriopoulou1*, Panagiotis T Diamantopoulos, MD, PhD1*, Nefeli Giannakopoulou1*, Dimitra Vlachopoulou1*, Panagiota Katsiampoura1*, Christos Stafylidis1*, Maria Dimou2, Athanasios Galanopoulos3*, Sotirios Papageorgiou, MD, PhD4*, Eleftheria Hatzimichael5*, Vassiliki Pappa, MD6*, Kotsianidis Ioannis7*, Argiris Symeonidis, MD, PhD8, Panayiotis Panayiotidis, MD2 and Nora-Athina Viniou, MD, PhD1

1Hematology Unit, First Department of Internal Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece
2First Propedeutic Department of Internal Medicine, School of Medicine, National and Kapodistrian University of Athens, Greece,, Athens, Greece
3Department of Clinical Hematology, G. Gennimatas Hospital, Athens, GRC
4Second Department of Internal Medicine, Hematology Unit, Attikon University General Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
5Department of Haematology, University Hospital of Ioannina, Ioannina, Greece
6Second Department of Internal Medicine and Research Institute, Attikon University General Hospital, Athens, Greece
7Department of Hematology, Democritus University of Thrace Medical School, Alexandroupolis, Greece
8Hematology Division, Department of Internal Medicine, University of Patras, Patras, Greece

Marie Solange Flores-Moran, MD1*, Leonor Arenillas, MD, PhD2,3*, Ana Ferrer, MD, PhD2,3*, Felix Lopez-Cadenas, MD4*, Sara Garcia-Avila, MD4*, Concepción Fernández, PhD3,5*, Antonio Salar, MD, PhD4* and Xavier Calvo, MD, PhD2,3*

1Hematology Department, Hospital del Mar, Barcelona, Cataluña, Spain
2Group of Translational Research on Hematological Neoplasms, Hospital del Mar-IMIM, Barcelona, Spain
3Pathology Department, Hospital del Mar, Barcelona, Spain
4Hematology Department, Hospital del Mar, Barcelona, Spain
5Group of Applied Clinical Research in Hematology. Cancer research program-IMIM, Barcelona, Spain

Chung Hoow Kok, PhD, BSc1,2, Elizabeth Ngoc Hoa Tran, PhD2,3*, Dariusz Ladon4*, Rakchha Chhetri, MBBS MHID Grad Cert. Biostat.2,5*, Anmol Baranwal, MBBS6*, Kirsty M Sharplin, MBBS5, Hassan B. Alkhateeb, MD6*, Deepak Singhal, MBBS, MD, FRACP, FRCPA1,5, Aref Al-Kali, MD6, Naseema Gangat, MBBS6, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA5,7, Mark R. Litzow, MD6, David M Ross, MBBS, PhD, FRACP, FRCPA2,5*, William J. Hogan, MB, BCh6, Ashanka Begna Kebede6*, Abhishek A. Mangaonkar, MBBS6, Mrinal M. M. Patnaik, MD6, Ayalew Tefferi, MD6, Naranie Shanmuganathan, MBBS, FRACP, FRCPA2,5, Sharad Kumar8*, Daniel Thomas, MD, PhD1,2, Mithun V. Shah, MD, PhD6 and Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA1,2,5

1Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia
2Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
3The University of Adelaide, Adelaide, Australia
4Genetic and Molecular Pathology, SA Pathology, Adelaide, Australia
5Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia
6Division of Hematology, Mayo Clinic, Rochester, MN
7Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
8Centre For Cancer Biology, SA Pathology, Adelaide, SA, AUS

Mithun V. Shah, MD, PhD1, Christopher N Hahn, PhD2, Rakchha Chhetri, MBBS MHID Grad Cert. Biostat.3,4*, Elizabeth Ngoc Hoa Tran, PhD3,5*, Deepak Singhal, MBBS, MD, FRACP, FRCPA4,6, William J. Hogan, MB, BCh1, Monika M Kutyna, MSc3,4,6*, Hassan B. Alkhateeb, MD1*, Aref Al-Kali, MD1, Naseema Gangat, MBBS1, Mark R. Litzow, MD1, Begna Kebede, MD1*, Abhishek A. Mangaonkar, MBBS1, Mrinal M. M. Patnaik, MD1, Ayalew Tefferi, MD1, Anmol Baranwal, MBBS1*, Naranie Shanmuganathan, MBBS, FRACP, FRCPA3,4, Sharad Kumar, PhD2*, Daniel Thomas, MD, PhD3,6, Chung Hoow Kok, PhD, BSc3,6 and Devendra Hiwase, MD, MBBS, PhD, FRACP, FRCPA3,4,6

1Division of Hematology, Mayo Clinic, Rochester, MN
2Centre for Cancer Biology, SA Pathology and University of South Australia, Adelaide, Australia
3Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
4Department of Haematology, Royal Adelaide Hospital, Adelaide, SA, Australia
5The University of Adelaide, Adelaide, Australia
6Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, SA, Australia

Sandra Novoa Jáuregui, MD1*, Laura Palomo, PhD2*, Ana Pérez, MD3*, Bárbara Tazón, PhD1*, Maria Julia Montoro, MD, PhD4*, Adoracion Blanco5*, Silvia Saumell, MD, PhD3*, Laura Gallur, MD3*, Eugenia Rivero, MD6*, Sara Garrido, MD1*, Marc Bosch Schips, MD1*, Sofia Laura Muzio, MD3*, Margarita Ortega, PhD1*, Antonieta Molero Yordi, MD1*, Francesc Bosch, MD, PhD3 and David Valcárcel, MD, PhD3

1Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
2Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
3Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), Barcelona, Spain
4Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), BARCELONA, Spain
5Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology Unit, Vall d’Hebron Institute of Oncology (VHIO), University Autonoma of Barcelona (UAB), Barcelona, AL, Spain
6Department of Hematology, University Hospital Arnau de Vilanova, Lleida, Spain

Maria Creignou, MD1,2*, Elsa Bernard, PhD3*, Michael Crowther, PhD4*, Anna Tranberg, MD1,2*, Elisabeth Ejerblad, MD5*, Lars Nilsson, MD, PhD6*, Hege Garelius, MD, PhD7*, Petar Antunovic, MD8*, Bengt Erik Holger Rasmussen, MD, PhD9*, Fryderyk Lorenz, MD10*, Gabriele Todisco, MD1*, Gunilla Walldin1*, Teresa Mortera-Blanco, PhD1*, Monika Jansson1*, Magnus Tobiasson, MD, PhD1,2*, Gustaf Edgren, MD PhD11,12*, Martin Jadersten, MD, PhD1,2*, Elli Papaemmanuil, PhD3 and Eva Hellström-Lindberg, MD, PhD1,2

1Center for Hematology and Regenerative Medicine (HERM), Department of Medicine (MedH), Karolinska Institutet, Huddinge, Sweden
2Department of Hematology, Karolinska University Hospital, Huddinge, Sweden
3Center for Molecular Oncology, Center for Heme Malignancies and Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA, New York, NY
4Red Door Analytics, Stockholm, Sweden
5Unit of Haematology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden
6Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden
7Department of Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, Göteborg, Sweden
8Department of Hematology, University Hospital in Linköping, Linköping, Sweden
9Department of Hematology, Örebro University Hospital, Örebro, Sweden
10Department of Hematology, University Hospital of Umeå, Umeå, Sweden
11Department of Cardiology, Södersjukhuset, Stockholm, Sweden
12Department of Medicine (MedS), Karolinska Institutet, Solna, Sweden

Uwe Platzbecker, MD1, Valeria Santini, MD, PhD2*, Rami S. Komrokji3, Amer M. Zeidan, MD4, Guillermo Garcia-Manero, MD5, Rena Buckstein6, Esther Natalie Oliva, MD7, Veronika Pozharskaya8*, Xianwei Ha8*, Jose Alberto Nadal, PhD, MSc9*, Dimana Miteva9* and Pierre Fenaux10

1Department for Hematology, Cell Therapy and Hemostaseology, University of Leipzig Medical Center, Leipzig, Germany
2University of Florence, Florence, Italy
3Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
4Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
7Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
8Bristol Myers Squibb, Princeton, NJ
9Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
10Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France

Zaker I. Schwabkey, MD1, Amin Azem, MD2*, Najla Al Ali, MS2, Somedeb Ball, MD3*, Luis E. E. Aguirre, MD2, Akriti G Jain, MD4, Avani M Singh, MD5, Sara M Tinsley-Vance, PhD, ANP3, Onyee Chan, MD2, Jeffrey E. Lancet, MD2, Kendra Sweet, MD3, Andrew Kuykendall, MD3, Eric Padron, MD2, David A. Sallman, MD2 and Rami S. Komrokji6

1Division of Hematology and Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
4Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, WESLEY CHAPEL, FL
5Division of Hematology and Oncology, USF / Moffitt Cancer Center & Research Institute, Tampa, FL
6H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Michael Pfeilstocker, Univ.-Prof., MD, MBA1,2, Heinz Tuechler3*, Lionel Ades4, Jaroslav Cermak, MD, PhD5, Fatiha Chermat6*, Matteo G. Della Porta, MD7*, Pierre Fenaux8, Guillermo Garcia-Manero, MD9, Ulrich Germing10*, Detlef Haase, MD, PhD11*, Andrea Kuendgen, MD12*, Michael Luebbert, MD13, Silvia Maria Meira Magalhaes, MD, PhD 14, Luca Malcovati, MD15,16, Yasushi Miyazaki, MD17, Guillermo Sanz, MD, PhD18,19,20,21, Valeria Santini, MD22, Mikkael A. Sekeres, MD23, Matthew J Walter, MD24,25, Peter Valent, MD2,26 and Peter L Greenberg, MD27

13rd Medical Department, Hematology & Oncology, Hanuschkrankenhaus, Vienna, Austria
2Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria
33rd Med Dept, Hanusch Hospital, Vienna, Austria
4Department of Hematology and Bone Marrow Transplantation, Hôpital Saint-Louis, Assistance Publique des Hôpitaux de Paris (AP-HP), Paris, France
5Dep. of Clinical Hematology, Inst. of Hematology & Blood Transfusion, Prague, Czech Republic
6Service d'Hématologie Séniors, Hôpital Saint-Louis, Paris, France
7Department of Biomedical Sciences, Humanitas University, Milan, Italy
8Université de Paris, Hematology department, Saint-Louis hospital, APHP, Paris, France
9University of Texas, MD Anderson Cancer Center, Houston, TX
10Dept. of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
11Clinics of Hematology and Medical Oncology, University Medicine Göttingen, Göttingen, Germany
12Heinrich Heine University, Department of Hematology, Oncology, and Clinical Immunology, Duesseldorf, Germany
13Clinic of Internal Medicine I, University Hospital Freiburg, Freiburg, Germany
14Department of Clinical Medicine; Cancer Cytogenomics Laboratory, Drug Research and Development Center, Universidade Federal do Ceará, Fortaleza, Brazil
15Department of Hematology Oncology, IRCCS Policlinico S. Matteo Foundation, Pavia, Italy
16Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Pavia, Italy
17Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan
18CIBERONC, Instituto Carlos III, Madrid, Spain
19Istituto de Investigación Sanitaria La Fe, Valencia, Spain
20Hematology Deparment, Health Research Institute La Fe, Valencia, Spain
21Hematology Department, Hospital Universitario i Politècnic La Fe, Valencia, Spain
22DMSC, MDS Unit, AOU Careggi, University of Florence, Firenze, Italy
23Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
24Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, Saint Louis, MO
25Washington University in St. Louis, St. Louis, MO
26Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
27Division of Hematology, Department of Medicine, Stanford University Medical Center, Stanford, CA

*signifies non-member of ASH